Lim, Kyung-EunHoggatt, April M.Bullock, Whitney A.Horan, Daniel J.Yokota, HirokiPavalko, Frederick M.Robling, Alexander G.2023-04-122023-04-122020-12Lim KE, Hoggatt AM, Bullock WA, et al. Pten deletion in Dmp1-expressing cells does not rescue the osteopenic effects of Wnt/β-catenin suppression. J Cell Physiol. 2020;235(12):9785-9794. doi:10.1002/jcp.29792https://hdl.handle.net/1805/32353Skeletal homeostasis is sensitive to perturbations in Wnt signaling. Beyond its role in bone, Wnt is a major target for pharmaceutical inhibition in a wide range of diseases, most notably cancers. Numerous clinical trials for Wnt-based candidates are currently underway, and Wnt inhibitors will likely soon be approved for clinical use. Given the bone-suppressive effects accompanying Wnt inhibition, there is a need to expose alternate pathways/molecules that can be targeted to counter the deleterious effects of Wnt inhibition on bone properties. Activation of the Pi3k/Akt pathway via Pten deletion is one possible osteoanabolic pathway to exploit. We investigated whether the osteopenic effects of β-catenin deletion from bone cells could be rescued by Pten deletion in the same cells. Mice carrying floxed alleles for Pten and β-catenin were bred to Dmp1-Cre mice in order to delete Pten alone, β-catenin alone, or both genes, from the late-stage osteoblast/osteocyte population. Mice were assessed for bone mass, density, strength, and formation parameters to evaluate the potential rescue effect of Pten deletion in Wnt-impaired mice. Pten deletion resulted in high bone mass and β-catenin deletion resulted in low bone mass. Compound mutants had bone properties similar to β-catenin mutant mice, or surprisingly in some assays, were further compromised beyond β-catenin mutants. Pten inhibition, or one of its downstream nodes, is unlikely to protect against the bone-wasting effects of Wnt/βcat inhibition. Other avenues for preserving bone mass in the presence of Wnt inhibition should be explored to alleviate the skeletal side effects of Wnt inhibitor-based therapies.en-USPublisher PolicyPtenAktWntβ-cateninOsteoporosisArticle